Oral Genome Point-of-Care Saliva Testing Recognized Under Newly Approved 2026 CDT Codes
Oral Genome announced today that its point-of-care, saliva-based test kits are eligible under newly approved CDT codes for 2026, marking a significant advancement in the integration of preventive saliva testing into routine dental care.
The updated CDT codes formally recognize in-office saliva testing, reflecting technological progress that allows dental professionals to perform saliva analysis chairside without the need to send samples to external laboratories. This recognition provides clinicians with a clear and standardized pathway to document and code point-of-care saliva testing as part of preventive care delivery.
Inclusion within the CDT framework directly supports Oral Genome’s mission to shift oral healthcare toward earlier risk identification and more proactive intervention—making prevention more accessible, actionable, and embedded into everyday clinical workflows.
“This represents a meaningful step toward upstream prevention,” said Dr. Tina Saw, Founder and CEO of Oral Genome. “When clinicians can identify risk earlier and intervene sooner, we reduce disease burden, lower long-term healthcare costs, and expand access to care. Recognizing point-of-care saliva testing supports a system that prioritizes prevention over reaction.”
The 2026 CDT updates reflect a broader movement toward prevention-first care models and provide dental practices with greater clarity and confidence in adopting innovative technologies that support patient-centered outcomes and long-term oral health.
Additional information on the 2026 CDT updates is available through the American Dental Association and provider-focused guidance published by Delta Dental:
- American Dental Association CDT Update: https://adanews.ada.org/ada-news/2025/september/new-cdt-codes-you-should-know-for-2026/
- Delta Dental CDT Summary for Providers: https://www1.deltadentalins.com/content/dam/ddins/en/pdf/blogs/fyi-online/2025/cdt-summary-provider.pdf
About Oral Genome
Oral Genome advances preventive oral healthcare through point-of-care saliva testing and technology-driven solutions designed to support early risk identification, improved access to care, and more proactive clinical decision-making.
